Wednesday 11 November 2015, Amsterdam
The report, now available on ASDReports, “Drug Delivery Technology Market Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Liquid), Nasal (Drop), Topical (Solid), Implantable (Active), Transmucosal (Oral)), End User (Hospital, ASC, Home Care) -Forecast to 2020”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the drug delivery technology market along with estimates and forecasts of the revenue and market share analysis.
The Drug Delivery Technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Drug delivery technology market offers a promising approach for the delivery of various kinds of drugs that have different molecular formulation. Drug delivery technology is aimed at maximizing the drug delivery at the targeted site so as to increase the efficiency of drug and proposing improved patient compliance.
The report segments the drug delivery technology market on the basis of route of administration, end users, and regions. On the basis of route of administration, oral drug delivery technology segment is expected to account for the largest share in 2015, closely followed by the injectable drug delivery technology segment. The topical drug delivery technology segment is expected to grow at the highest CAGR during the forecast period, owing to b convenient and easy to use, right dosage to the right place, painless, non-invasive, superior spread ability, and patient compliance. The oral drug delivery technology segment is further segmented into solid oral drug delivery technology, semi-solid oral drug delivery technology, and liquid oral drug delivery technology. The injectable drug delivery technology is further segmented into formulations and devices.
On the basis of end user, the drug delivery technology market is segmented into hospitals, ASCs/clinics, home care settings, diagnostic centers and other end users.
Geographically, the market is dominated by North America, followed by Europe. North America is expected to account for the largest share of the drug delivery technology market in 2015, with Asia having the highest growth rate during the forecast period.
Key players in the drug delivery technology market include Pfizer, Inc. (U.S.), Roche (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Novartis AG (Switzerland), and Bayer AG (Germany).
ASDReports.com Media contact: S. Koopman -
Marketing and Communications
ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : email@example.com
back to News